申请人:MERCK SHARP & DOHME LTD.
公开号:EP0481676A1
公开(公告)日:1992-04-22
A class of 4-hydroxy-2-(1 H)-quinolone derivatives, substituted at the 3-position by an optionally substituted aryl substituent, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA receptor antagonist.
一类 4-羟基-2-(1H)-喹诺酮衍生物在 3 位被任选取代的芳基取代基取代,是 NMDA 受体的选择性非竞争性拮抗剂和/或 AMPA 受体的拮抗剂,因此可用于治疗神经退行性疾病、惊厥或精神分裂症等需要施用 NMDA 和/或 AMPA 受体拮抗剂的疾病。